# Knowledge and Perceptions of Mental Health Care Users on Cannabis Decriminalization > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/mental-health-patients-cannabis-perceptions/ > **Published:** 2026-04-13T20:51:11-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T10:22:44-04:00 > **Clinical Summary:** Explore mental health patients cannabis perceptions on decriminalization and how it impacts disclosure and treatment in psychiatric care. --- ✦ New CED Clinical Relevance  #70Notable Clinical Interest  Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News  |  CED Clinic Mental HealthPolicyPatient PerspectivesDisclosure[Cannabis Use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/) Why This Matters Mental health patients often use cannabis therapeutically, yet their perspectives on decriminalization policy are rarely studied systematically. Understanding patient knowledge and perceptions helps clinicians navigate conversations about legal cannabis use in psychiatric care contexts. Clinical Summary This appears to be a South African study examining mental health care users’ knowledge and attitudes toward [cannabis decriminalization](https://cedclinic.com/gateway-drug-myth/) policy. Without access to the full study methodology and findings, the clinical significance remains unclear. Patient perspectives on cannabis policy can influence disclosure patterns and treatment adherence in mental health settings. Dr. Caplan’s Take “I need to see the actual data before commenting on clinical implications. Patient attitudes toward cannabis policy matter clinically, but only if we understand what drives those perceptions and how they affect care-seeking behavior.” Clinical Perspective 🧠 Clinicians should assess how local cannabis policies affect patient disclosure about use patterns. Creating non-judgmental spaces for cannabis discussions remains important regardless of legal status, as therapeutic relationships depend on honest communication about all substances patients use. 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/forum/cannabis-industry/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20Knowledge%20and%20perceptions%20of%20mental%20health%20care%20users%20on%20decriminalisation%20of%20ca...%20%40drcaplan&url=https%3A//repository.up.ac.za/items/2916af68-9694-4b86-8487-87a8166da1a4)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A//repository.up.ac.za/items/2916af68-9694-4b86-8487-87a8166da1a4)[🦥 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20Knowledge%20and%20perceptions%20of%20mental%20health%20care%20users%20on%20decriminalisation%20of%20ca...%20--%20via%20%40drcaplan.bsky.social%20https%3A//repository.up.ac.za/items/2916af68-9694-4b86-8487-87a8166da1a4)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) 📰 Source: [https://repository.up.ac.za/items/2916af68-9694-4b86-8487-87a8166da1a4](https://repository.up.ac.za/items/2916af68-9694-4b86-8487-87a8166da1a4) Table of Contents - [FAQ](#FAQ)[What is the clinical relevance rating of this cannabis news?](#What_is_the_clinical_relevance_rating_of_this_cannabis_news) - [What main topics does this cannabis news cover?](#What_main_topics_does_this_cannabis_news_cover) - [Why is this marked as “New” content?](#Why_is_this_marked_as_8220New8221_content) - [What does “Notable Clinical Interest” mean for healthcare providers?](#What_does_8220Notable_Clinical_Interest8221_mean_for_healthcare_providers) - [How does this relate to patient disclosure requirements?](#How_does_this_relate_to_patient_disclosure_requirements) - [Related](#Related) ## FAQ #### What is the clinical relevance rating of this cannabis news? This article has been assigned CED Clinical Relevance #70, indicating “Notable Clinical Interest.” This rating suggests the content contains emerging findings or policy developments that warrant close monitoring by healthcare professionals. #### What main topics does this cannabis news cover? The article covers four key areas: Mental Health, Policy, Patient Perspectives, and Disclosure. These topics suggest the content addresses both clinical applications and regulatory aspects of cannabis use. #### Why is this marked as “New” content? The “New” designation indicates this is recently published or updated information from CED Clinic. This ensures healthcare providers are aware of the most current developments in cannabis-related clinical practice. #### What does “Notable Clinical Interest” mean for healthcare providers? This classification indicates the content contains emerging findings or policy developments worth monitoring closely. It suggests the information may impact clinical decision-making or [patient care](https://cedclinic.com/cannabis-cardiovascular-risk-impact/) approaches in the near future. #### How does this relate to patient disclosure requirements? The “Disclosure” tag suggests this article addresses important considerations about patient communication regarding cannabis use. This likely includes guidance on discussing cannabis treatments, potential interactions, or legal considerations with patients. [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence ‘Less red tape:’ Public and political perception of cannabis continues to change Explore how evolving public and political views on cannabis influence policy and patient attitudes. Read More [Exploring Cannabinoids and Their Role in Patient Care](https://cedclinic.com/cannabinoid-therapeutics-clinical-practice-patient-care/) Learn about cannabinoids' therapeutic potential and their impact on patient care strategies. [Discover Insights](https://cedclinic.com/cannabinoid-therapeutics-clinical-practice-patient-care/) [A majority of Pennsylvania voters believe adult-use cannabis should be legal](https://cedclinic.com/adult-use-cannabis-legalization-pennsylvania-voter-support/) Understand public opinion trends on adult-use [cannabis legalization](https://cedclinic.com/the-forgotten-history-of-hemp-in-america/) and implications for policy. [Explore Public Opinion](https://cedclinic.com/adult-use-cannabis-legalization-pennsylvania-voter-support/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).